We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $434M
1-Year Est. Return 19.64%
This Fund
S&P 500
This Quarter Est. Return
+3.94%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$414M
AUM Growth
-$48M
Cap. Flow
-$45M
Cap. Flow %
-10.86%
Top 10 Hldgs %
9.94%
Holding
372
New
102
Increased
39
Reduced
38
Closed
120

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$4.68M
2
CHKP icon
Check Point Software Technologies
CHKP
+$4.06M
3
CVS icon
CVS Health
CVS
+$3.31M
4
TR icon
Tootsie Roll Industries
TR
+$3.28M
5
APTV icon
Aptiv
APTV
+$3.03M

Top Sells

Rank Stock Value
1
TGTX icon
TG Therapeutics
TGTX
+$4.55M
2
ATEN icon
A10 Networks
ATEN
+$3.81M
3
LULU icon
lululemon athletica
LULU
+$3.74M
4
GLOB icon
Globant
GLOB
+$3.61M
5
B
Barrick Mining
B
+$3.45M

Sector Composition

Rank Sector Weight
1 Healthcare 26.94%
2 Technology 21.13%
3 Consumer Staples 11.57%
4 Consumer Discretionary 10.57%
5 Financials 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QCOM icon
1
Qualcomm
QCOM
$197B
$4.67M 1.13%
+27,300
New +$4.68M
ETSY icon
2
Etsy
ETSY
$6.74B
$4.66M 1.13%
84,000
+42,000
+100% +$2.56M
UI icon
3
Ubiquiti
UI
$34.5B
$4.65M 1.12%
8,400
+4,200
+100% +$2.66M
UNFI icon
4
United Natural Foods
UNFI
$2.79B
$4.24M 1.03%
126,000
-31,500
-20% -$1.17M
CHTR icon
5
Charter Communications
CHTR
$15.5B
$3.95M 0.95%
18,900
– –
G icon
6
Genpact
G
$5.93B
$3.93M 0.95%
84,000
– –
ACAD icon
7
Acadia Pharmaceuticals
ACAD
$4.75B
$3.93M 0.95%
147,000
+21,000
+17% +$502K
CHKP icon
8
Check Point Software Technologies
CHKP
$14.1B
$3.9M 0.94%
+21,000
New +$4.06M
EXEL icon
9
Exelixis
EXEL
$14.1B
$3.68M 0.89%
84,000
-21,000
-20% -$869K
HALO icon
10
Halozyme
HALO
$12.3B
$3.53M 0.85%
52,500
+21,000
+67% +$1.41M
CNXC icon
11
Concentrix
CNXC
$1.78B
$3.49M 0.84%
84,000
+42,000
+100% +$1.7M
NUTX
12
Nutex Health
NUTX
$1.49B
$3.46M 0.84%
+21,000
New +$2.79M
CVS icon
13
CVS Health
CVS
$117B
$3.33M 0.81%
+42,000
New +$3.31M
SEZL
14
Sezzle
SEZL
$3.95B
$3.33M 0.81%
52,500
+14,700
+39% +$1M
CL icon
15
Colgate-Palmolive
CL
$69.4B
$3.32M 0.8%
42,000
– –
PCRX icon
16
Pacira BioSciences
PCRX
$993M
$3.26M 0.79%
126,000
+21,000
+20% +$499K
PGNY icon
17
Progyny
PGNY
$2.1B
$3.24M 0.78%
126,000
+21,000
+20% +$483K
URBN icon
18
Urban Outfitters
URBN
$6.6B
$3.16M 0.76%
42,000
+10,500
+33% +$743K
TR icon
19
Tootsie Roll Industries
TR
$2.85B
$3.08M 0.74%
+86,520
New +$3.28M
NEM icon
20
Newmont
NEM
$128B
$3.05M 0.74%
30,500
-20,500
-40% -$1.85M
PEP icon
21
PepsiCo
PEP
$183B
$3.01M 0.73%
21,000
– –
CSIQ icon
22
Canadian Solar
CSIQ
$770M
$3M 0.72%
+126,000
New +$2.75M
VZ icon
23
Verizon
VZ
$207B
$2.99M 0.72%
+73,500
New +$2.98M
NBIX icon
24
Neurocrine Biosciences
NBIX
$15.2B
$2.98M 0.72%
21,000
– –
DLO icon
25
dLocal
DLO
$4.21B
$2.97M 0.72%
+210,000
New +$2.96M
1
2 3 4 5

Similar funds

NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
DCM
Divisar Capital Management San Francisco, California $434M AUM 170.22% 1-Year Est. Return
SCP
Seafarer Capital Partners Larkspur, California $434M AUM 22.8% 1-Year Est. Return
NRC
New Republic Capital Charlotte, North Carolina $434M AUM 31.16% 1-Year Est. Return
CEI
Clark Estates Inc New York $434M AUM 15% 1-Year Est. Return
CFG
Carr Financial Group Worcester, Massachusetts $434M AUM 28.34% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $434M AUM 68.57% 1-Year Est. Return
OCPWS
One Charles Private Wealth Services Hingham, Massachusetts $434M AUM 22.37% 1-Year Est. Return

Hussman Strategic Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Hussman Strategic Advisors held 372 positions worth $414M, down 10% from $462M the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Hussman Strategic Advisors withdrew a net $45M in Q4 2025, closing 120 positions and reducing 38 holdings. Its most notable exit was TG Therapeutics, an estimated $4.55M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Hussman Strategic Advisors opened a new position in Qualcomm worth $4.67M.

  • Hussman Strategic Advisors's largest Q4 2025 buy was Qualcomm: 27,300 shares worth $4.67M.
  • Hussman Strategic Advisors added most to Ubiquiti in Q4 2025, an estimated $2.66M increase.
  • Hussman Strategic Advisors's biggest Q4 2025 reduction was Barrick Mining, cutting an estimated $3.45M.
  • Hussman Strategic Advisors fully exited TG Therapeutics in Q4 2025, selling an estimated $4.55M.
  • Hussman Strategic Advisors's ten largest holdings make up 9.9% of its $414M portfolio in Q4 2025.
  • Hussman Strategic Advisors opened 102 new positions and closed 120 in Q4 2025.
  • Hussman Strategic Advisors's portfolio value fell 10% quarter-over-quarter to $414M.

Based on Hussman Strategic Advisors's 13F filing for Q4 2025, filed 2 Feb 2026.